Iron Metabolism: Interactions with Normal and Disordered Erythropoiesis
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Hemoglobinopathies and other disorders of erythroid cells are often associated with abnormal iron homeostasis. We review the molecular physiology of intracellular and systemic iron regulation, and the interactions between erythropoiesis and iron homeostasis. Finally, we discuss iron disorders that affect erythropoiesis as well as erythroid disorders that cause iron dysregulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · cited 5×
“Hepcidin synthesis is transcriptionally regulated by iron through the BMP receptor complex and its Smad pathway (shades of blue) and by inflammation predominantly via the IL-6 receptor and its JAK-STAT3 pathway (green).”
BackgroundInfluentialSelf-citationPigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697 · cited 1×
“During infections and inflammation, the synthesis and serum concentrations of hepcidin are greatly increased (Pigeon et al. 2001; Nicolas et al. 2002; Nemeth et al. 2003, 2004; Ganz et al. 2008).”
BackgroundHepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417 · cited 5×
“Hepcidin synthesis is transcriptionally regulated by iron through the BMP receptor complex and its Smad pathway (shades of blue) and by inflammation predominantly via the IL-6 receptor and its JAK-STAT3 pathway (green).”
BackgroundInfluentialSelf-citationNicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233
Heme oxygenase 1 is required for mammalian iron reutilization
Poss, K. D., & Tonegawa, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10919 · Cited by 1,016
Interleukin-6 induces hepcidin expression through STAT3
Wrighting, D. M., & Andrews, N. C. (2006) · Blood · doi:10.1182/blood-2006-06-027631 · Cited by 983
Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis
Papanikolaou, G., Samuels, M. E., Ludwig, E. H., MacDonald, M. L. E., Franchini, P. L., Dubé, M.-P., Andres, L., MacFarlane, J., Sakellaropoulos, N., Politou, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1274 · Cited by 974 · cited 2×
“Two other proteins, GPI-linked hemojuvelin (Papanikolaou et al. 2004) and the Liver Spleen Inflammation Hepcidin H epcidin Hepcidin Fpn Fpn Duodenum Erythropoietic signal Bone marrow Iron signals Fpn Plasma Fe-Tf Erythrocytes Liver Fe Figure 2.”
BackgroundSelf-citationHigh levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., et al. (2007) · Nature Medicine · doi:10.1038/nm1629 · Cited by 854 · cited 1×
“…factor (GDF) 15 and twisted gastrulation (TWSG) 1, have been proposed to play a role in pathological hepcidin suppression during ineffective erythropoiesis (Tanno et al. 2007, 2009; Casanovas et al. 2011) but their specific regulatory role in iron homeostasis or pathology remains to be established.”
BackgroundSelf-citationBMP6 is a key endogenous regulator of hepcidin expression and iron metabolism
Andriopoulos Jr, B., Corradini, E., Xia, Y., Faasse, S. A., Chen, S., Grgurevic, L., Knutson, M. D., Pietrangelo, A., Vukicevic, S., Lin, H. Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.335 · Cited by 769
The Steap proteins are metalloreductases
Ohgami, R. S., Campagna, D. R., McDonald, A., & Fleming, M. D. (2006) · Blood · doi:10.1182/blood-2006-02-003681 · Cited by 744 · cited 1×
“1), assisted perhaps by Steap2 and Steap4 (Ohgami et al. 2006).”
BackgroundIron-Responsive Elements: Regulatory RNA Sequences That Control mRNA Levels and Translation
Casey, J. L., Hentze, M. W., Koeller, D. M., Caughman, S. W., Rouault, T. A., Klausner, R. D., & Harford, J. B. (1988) · Science · doi:10.1126/science.2452485 · Cited by 709 · cited 2×
“Target mRNAs contain IREs that form characteristic stem-loop structures either in the 50 region, where IRP binding represses translation and decreases protein synthesis, or in the 30 region where IRP binding prevents endonucleases from cleaving sensitive regions of the mRNA, thus stabilizing mRNA and increasing protei…”
BackgroundMutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)
Finberg, K. E., Heeney, M. M., Campagna, D. R., Aydınok, Y., Pearson, H. A., Hartman, K. R., Mayo, M. M., Samuel, S. M., Strouse, J. J., Markianos, K., et al. (2008) · Nature Genetics · doi:10.1038/ng.130 · Cited by 675
Lack of the bone morphogenetic protein BMP6 induces massive iron overload
Meynard, D., Kautz, L., Darnaud, V., Canonne-Hergaux, F., Coppin, H., & Roth, M.-P. (2009) · Nature Genetics · doi:10.1038/ng.320 · Cited by 587
The serine protease TMPRSS6 is required to sense iron deficiency
Du, X., She, E., Gelbart, T., Truksa, J., Lee, P., Xia, Y., Khovananth, K., Mudd, S., Mann, N., Moresco, E. M. Y., et al. (2008) · Science · doi:10.1126/science.1157121 · Cited by 578
STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation
Verga Falzacappa, M. V., Vujic Spasic, M., Kessler, R., Stolte, J., Hentze, M. W., & Muckenthaler, M. U. (2007) · Blood · doi:10.1182/blood-2006-07-033969 · Cited by 567 · cited 2×
“3), with STAT3 binding to canonical binding sites in the hepcidin promoter, leading to transcriptional stimulation of hepcidin synthesis (Wrighting and Andrews 2006; Pietrangelo et al. 2007; Verga Falzacappa et al. 2007).”
BackgroundSilvestri, L., Pagani, A., Nai, A., De Domenico, I., Kaplan, J., & Camaschella, C. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.012 · Cited by 555 · cited 2×
“…protease matriptase 2 (MT2, also called transmembrane serine proteinase 6, TMPRSS6) (Du et al. 2008) respectively enhance and dampen BMP signaling, with hemojuvelin acting as a BMP pathway coreceptor, and MT2 exerting its effect by an inactivating cleavage of hemojuvelin (Silvestri et al. 2008).”
BackgroundA cytosolic iron chaperone that delivers iron to ferritin
Shi, H., Bencze, K. Z., Stemmler, T. L., & Philpott, C. C. (2008) · Science · doi:10.1126/science.1157643 · Cited by 536 · cited 1×
“Because of its chemical reactivity, iron is chaperoned in the cytoplasm, at least in part by multifunctional poly(RC)binding proteins (PCBPs) (Shi et al. 2008).”
BackgroundHIF-2α, but not HIF-1α, promotes iron absorption in mice
Mastrogiannaki, M., Matak, P., Keith, B., Simon, M. C., Vaulont, S., & Peyssonnaux, C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38499 · Cited by 502 · cited 1×
“In support of the potential role of HIF in iron regulation, tissue-specific deletion of HIF2a in mouse enterocytes decreased intestinal iron absorption as well as the expression of DMT1 in enterocytes (Mastrogiannaki et al. 2009).”
BackgroundSuppression of hepcidin during anemia requires erythropoietic activity
Pak, M., Lopez, M. A., Gabayan, V., Ganz, T., & Rivera, S. (2006) · Blood · doi:10.1182/blood-2006-06-028787 · Cited by 472 · cited 1×
“…now appears that this is an indirect effect dependent on increased erythropoietin production and the resulting expansion of erythroid precursors in the marrow (Pak et al. 2006; Vokurka et al. 2006; Mastrogiannakietal.2011)andnotadirecteffect of hypoxia-regulated pathways on the hepcidin promoter.”
BackgroundSelf-citationRegulators of iron balance in humans [see comments]
Finch, C. (1994) · Blood · doi:10.1182/blood.v84.6.1697.1697 · Cited by 455
Hepcidin in iron overload disorders
Papanikolaou, G., Tzilianos, M., Christakis, J. I., Bogdanos, D., Tsimirika, K., MacFarlane, J., Goldberg, Y. P., Sakellaropoulos, N., Ganz, T., & Nemeth, E. (2005) · Blood · doi:10.1182/blood-2004-12-4844 · Cited by 445 · cited 5×
“…under pathological conditions of expanded but ineffective erythropoiesis, seen in b-thalassemia and congenital dyserythropoietic anemias (Adamsky et al. 2004; Papanikolaou et al. 2005) where the large number of apoptosing erythrocyte precursors could generate additional suppressive factors.”
BackgroundInfluentialSelf-citationControl of iron homeostasis by an iron-regulated ubiquitin ligase
Vashisht, A. A., Zumbrennen, K. B., Huang, X., Powers, D. N., Durazo, A., Sun, D., Bhaskaran, N., Persson, A., Uhlen, M., Sangfelt, O., et al. (2009) · Science · doi:10.1126/science.1176333 · Cited by 429
Liver iron concentrations and urinary hepcidin in -thalassemia
Origa, R., Galanello, R., Ganz, T., Giagu, N., Maccioni, L., Faa, G., & Nemeth, E. (2007) · Haematologica · doi:10.3324/haematol.10842 · Cited by 365 · cited 1×
“In these disorders, hepcidin is suppressed (Adamsky et al. 2004; Papanikolaou et al. 2005; Kearneyet al. 2007; Casanovas et al. 2011) causing hyperabsorption of dietary iron and iron overload even in the absence of erythrocyte transfusions (Origa et al. 2007).”
BackgroundSelf-citationTanno, T., Porayette, P., Sripichai, O., Noh, S.-J., Byrnes, C., Bhupatiraju, A., Lee, Y. T., Goodnough, J. B., Harandi, O., Ganz, T., et al. (2009) · Blood · doi:10.1182/blood-2008-12-195503 · Cited by 352
Self-citationSTAT3 Is Required for IL-6-gp130–Dependent Activation of Hepcidin In Vivo
Pietrangelo, A., Dierssen, U., Valli, L., Garuti, C., Rump, A., Corradini, E., Ernst, M., Klein, C., & Trautwein, C. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.10.018 · Cited by 315 · cited 1×
“3), with STAT3 binding to canonical binding sites in the hepcidin promoter, leading to transcriptional stimulation of hepcidin synthesis (Wrighting and Andrews 2006; Pietrangelo et al. 2007; Verga Falzacappa et al. 2007).”
BackgroundZhang, D.-L., Hughes, R. M., Ollivierre-Wilson, H., Ghosh, M. C., & Rouault, T. A. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.006 · Cited by 281 · cited 2×
“As an example, systemic adaptation to iron deficiency may be facilitated by a ferroportin mRNA isoform that lacks IRE, which may allow iron-transporting duodenal enterocytes to deliver iron to plasma for systemic needs even if the enterocyte is sensing iron deficiency, and may transfer iron from erythroid cells to oth…”
BackgroundHepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice
Gardenghi, S., Ramos, P., Marongiu, M. F., Melchiori, L., Breda, L., Guy, E., Muirhead, K., Rao, N., Roy, C. N., Andrews, N. C., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41717 · Cited by 220 · cited 1×
“…of plasma iron in this condition may further unbalance heme and globin synthesis and worsen ineffective erythropoeisis, and conversely, that restricting the iron supply through the administration of apotransferrin or hepcidin may improve erythropoiesis (Gardenghi et al. 2010a,b; Li et al. 2010).”
BackgroundSelf-citationActivation of the HIF Prolyl Hydroxylase by the Iron Chaperones PCBP1 and PCBP2
Nandal, A., Ruiz, J. C., Subramanian, P., Ghimire-Rijal, S., Sinnamon, R. A., Stemmler, T. L., Bruick, R. K., & Philpott, C. C. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.015 · Cited by 204
Corradini, E., Meynard, D., Wu, Q., Chen, S., Ventura, P., Pietrangelo, A., & Babitt, J. L. (2011) · Hepatology · doi:10.1002/hep.24359 · Cited by 194 · cited 2×
“It is not known with certainty how the concentration of iron-transferrin is sensed but ablation of HFE or TfR2, and especially the combined loss of both molecules, decreases hepcidin expression and interferes with the sensing of transient changes in iron-transferrin while preserving the increase in BMP6 and the chroni…”
BackgroundTransferrin therapy ameliorates disease in β-thalassemic mice
Li, H., Rybicki, A. C., Suzuka, S. M., von Bonsdorff, L., Breuer, W., Hall, C. B., Cabantchik, Z. I., Bouhassira, E. E., Fabry, M. E., & Ginzburg, Y. Z. (2010) · Nature Medicine · doi:10.1038/nm.2073 · Cited by 192
Ashby, D. R., Gale, D. P., Busbridge, M., Murphy, K. G., Duncan, N. D., Cairns, T. D., Taube, D. H., Bloom, S. R., Tam, F. W. K., Chapman, R., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.013136 · Cited by 191 · cited 2×
“In normal volunteers, the administration of erythropoietin was sufficient to lower serum hepcidin profoundly within less than 1 day, intheabsenceofanysignificantchanges inserum iron (Ashby et al. 2010).”
BackgroundUrinary hepcidin in congenital chronic anemias
Kearney, S. L., Nemeth, E., Neufeld, E. J., Thapa, D., Ganz, T., Weinstein, D. A., & Cunningham, M. J. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.20616 · Cited by 172 · cited 2×
“Transfusions partially relieve the erythropoietin-driven expansion of ineffective erythropoiesis and raise hepcidin concentrations (Kearney et al. 2007) but cause iron overload owing to the iron content of transfused blood.”
BackgroundSelf-citationNramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo
Soe-Lin, S., Apte, S. S., Andriopoulos, B., Andrews, M. C., Schranzhofer, M., Kahawita, T., Garcia-Santos, D., & Ponka, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900808106 · Cited by 167
Verga Falzacappa, M. V., Casanovas, G., Hentze, M. W., & Muckenthaler, M. U. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0313-7 · Cited by 146
In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2
Maes, K., Nemeth, E., Roodman, G. D., Huston, A., Esteve, F., Freytes, C., Callander, N., Katodritou, E., Tussing-Humphreys, L., Rivera, S., et al. (2010) · Blood · doi:10.1182/blood-2010-03-274571 · Cited by 132
Self-citationDecreased hepcidin mRNA expression in thalassemic mice
Adamsky, K., Weizer, O., Amariglio, N., Breda, L., Harmelin, A., Rivella, S., Rachmilewitz, E., & Rechavi, G. (2004) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04734.x · Cited by 108 · cited 4×
“…prominent under pathological conditions of expanded but ineffective erythropoiesis, seen in b-thalassemia and congenital dyserythropoietic anemias (Adamsky et al. 2004; Papanikolaou et al. 2005) where the large number of apoptosing erythrocyte precursors could generate additional suppressive…”
BackgroundInfluentialTargeted deletion of the mouse Mitoferrin1 gene: from anemia to protoporphyria
Troadec, M.-B., Warner, D., Wallace, J., Thomas, K., Spangrude, G. J., Phillips, J., Khalimonchuk, O., Paw, B. H., Ward, D. M., & Kaplan, J. (2011) · Blood · doi:10.1182/blood-2010-11-319483 · Cited by 97
Iron control of erythroid development by a novel aconitase-associated regulatory pathway
Bullock, G. C., Delehanty, L. L., Talbot, A.-L., Gonias, S. L., Tong, W.-H., Rouault, T. A., Dewar, B., Macdonald, J. M., Chruma, J. J., & Goldfarb, A. N. (2010) · Blood · doi:10.1182/blood-2009-10-251496 · Cited by 85 · cited 2×
“The dual specificity of IRP1/aconitase may have a functional role in the regulation of erythropoiesis by iron availability, as the provision of the aconitase product isocitrate reverses some of the suppressive effect of iron deprivation on erythropoiesis and the enzymatic inhibition of aconitase has the opposite effec…”
Background
Cited by
Regulation of the Iron Homeostatic Hormone Hepcidin
Sangkhae, V., & Nemeth, E. (2017) · Advances in Nutrition · doi:10.3945/an.116.013961 · Cited by 443
Self-citationHemoglobin Variants: Biochemical Properties and Clinical Correlates
Thom, C. S., Dickson, C. F., Gell, D. A., & Weiss, M. J. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011858 · Cited by 336
“Exposure to oxidant drugs or toxins, genetic alterations in erythroid metHb reductase enzyme systems (Ganz and Nemeth 2012; Schechter 2012), or globin chain variants can predispose to methemoglobinemia.”
BackgroundThe physiological functions of iron regulatory proteins in iron homeostasis - an update
Zhang, D.-L., Ghosh, M. C., & Rouault, T. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00124 · Cited by 301
Waldvogel-Abramowski, S., Waeber, G., Gassner, C., Buser, A., Frey, B. M., Favrat, B., & Tissot, J.-D. (2014) · Transfusion Medicine and Hemotherapy · doi:10.1159/000362888 · Cited by 260
NCOA4 deficiency impairs systemic iron homeostasis
Bellelli, R., Federico, G., Matte’, A., Colecchia, D., Iolascon, A., Chiariello, M., Santoro, M., De Franceschi, L., & Carlomagno, F. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.065 · Cited by 248
Metadata
- Authors
- Ganz, T., & Nemeth, E.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-05-01
- Volume
- 2
- Issue
- 5
- Pages
- a011668-a011668
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2140582054
- Cited by
- 152
- References
- 38
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.